A Phase II Multi-center Study of High-Dose Cyclophosphamide and Antithymocyte Globulin Followed by Autologous Hematopoietic Cell Transplantation With Post Transplant Maintenance for the Treatment of Systemic Sclerosis
Phase: PHASE2
Conditions: Systemic Scleroderma
Sponsor: Fred Hutchinson Cancer Center



	

	h h
    
  
	
 

A

seueMess
	


  



	

lPtPIsIM